PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.\', \'Electron Microscopy Facility, RWTH Aachen University Hospital, Aachen, Germany.\', \'Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.\', \'Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.\', \'Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia.\', \'RWTH Centralized Biomaterial Bank (RWTH cBMB), RWTH Aachen University Hospital, Aachen, Germany.\', \'Department of Nephrology, RWTH Aachen University Hospital, Aachen, Germany.\', \'Department of Immunology, RWTH Aachen University Hospital, Aachen, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/1751-7915.13828
?:hasPublicationType
?:journal
  • Microbial biotechnology
is ?:pmid of
?:pmid
?:pmid
  • 33993637
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.275
?:rankingScore_hIndex
  • 48
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 RNA screening in routine pathology specimens.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all